cytogen corp said it will expand clinic trial it cancer imag technolog said new studi were anticip mid year said first phase human test begain octob technolog use monoclonc antibodi tag with radioisotop diagnos colorect cancer and sever cancer type said preliminari studi reveal antibodi combin was well toler patient studi reuter 